Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

Deep learning segmentation of orbital fat to calibrate conventional MRI for longitudinal studies.

Brown RA, Fetco D, Fratila R, Fadda G, Jiang S, Alkhawajah NM, Yeh EA, Banwell B, Bar-Or A, Arnold DL; Canadian Pediatric Demyelinating Disease Network.

Neuroimage. 2019 Dec 7:116442. doi: 10.1016/j.neuroimage.2019.116442. [Epub ahead of print]

PMID:
31821865
2.

High- and Low-Contrast Letter Acuity Perception Matures With Age in Normally Sighted Children.

Waldman AT, Lavery AM, Liu GW, Avery RA, Liu GT, Maguire MG, Ying GS, Banwell BL.

J Neuroophthalmol. 2019 Dec 3. doi: 10.1097/WNO.0000000000000821. [Epub ahead of print]

PMID:
31809367
3.

Factors associated with health care utilization in pediatric multiple sclerosis.

Marrie RA, O'Mahony J, Maxwell C, Ling V, Till C, Barlow-Krelina E, Yeh EA, Arnold DL, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Mult Scler Relat Disord. 2019 Nov 6;38:101511. doi: 10.1016/j.msard.2019.101511. [Epub ahead of print]

PMID:
31722282
4.

Acceptability of Standardized EEG Reporting in an Electronic Health Record.

Witzman S, Massey SL, Kessler S, Gonzalez-Giraldo E, Fridinger SE, Worden L, Lewin N, Dlugos D, Melamed S, Fitzgerald M, Fung FW, Ferruzi M, McNamee N, LaFalce D, Donnelly M, Haywood A, Allen-Napoli L, Banwell B, Abend NS.

J Clin Neurophysiol. 2019 Oct 28. doi: 10.1097/WNP.0000000000000639. [Epub ahead of print]

PMID:
31688354
5.

Slow-channel myasthenia due to novel mutation in M2 domain of AChR delta subunit.

Shen XM, Milone M, Wang HL, Banwell B, Selcen D, Sine SM, Engel AG.

Ann Clin Transl Neurol. 2019 Oct;6(10):2066-2078. doi: 10.1002/acn3.50902. Epub 2019 Sep 27.

6.

Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.

Waters P, Fadda G, Woodhall M, O'Mahony J, Brown RA, Castro DA, Longoni G, Irani SR, Sun B, Yeh EA, Marrie RA, Arnold DL, Banwell B, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

JAMA Neurol. 2019 Sep 23. doi: 10.1001/jamaneurol.2019.2940. [Epub ahead of print]

7.

Early neuroaxonal injury is seen in the acute phase of pediatric optic neuritis.

Wilbur C, Reginald YA, Longoni G, Grover SA, Wong AM, Mabbott DJ, Arnold DL, Marrie RA, Bar-Or A, Banwell B, Costello F, Yeh EA; Canadian Pediatric Demyelinating Disease Network.

Mult Scler Relat Disord. 2019 Nov;36:101387. doi: 10.1016/j.msard.2019.101387. Epub 2019 Sep 7.

PMID:
31539739
8.

Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS.

Deiva K, Huppke P, Banwell B, Chitnis T, Gärtner J, Krupp L, Waubant E, Stites T, Pearce GL, Merschhemke M.

J Neurol Neurosurg Psychiatry. 2019 Aug 29. pii: jnnp-2019-321124. doi: 10.1136/jnnp-2019-321124. [Epub ahead of print]

9.

Effects of Optic Neuritis, T2 Lesions, and Microstructural Diffusion Integrity in the Visual Pathway on Cortical Thickness in Pediatric-Onset Multiple Sclerosis.

Datta R, Sollee JR, Lavery AM, Ficerai-Garland G, Karoscik K, Liu G, Banwell BL, Waldman AT.

J Neuroimaging. 2019 Nov;29(6):760-770. doi: 10.1111/jon.12654. Epub 2019 Jul 18.

PMID:
31317617
10.

In memoriam: Prof. Rogier Q. Hintzen, MD, PhD (1963-2019).

Neuteboom RF, Banwell B.

Mult Scler. 2019 Aug;25(9):1209-1210. doi: 10.1177/1352458519858035. Epub 2019 Jun 20. No abstract available.

PMID:
31218909
11.

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.

Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, Geurts JJG, Paul F, Reich DS, Toosy AT, Traboulsee A, Wattjes MP, Yousry TA, Gass A, Lubetzki C, Weinshenker BG, Rocca MA.

Brain. 2019 Jul 1;142(7):1858-1875. doi: 10.1093/brain/awz144.

12.

High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study.

Marrie RA, O'Mahony J, Maxwell CJ, Ling V, Yeh EA, Arnold DL, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.

PLoS One. 2019 Jun 11;14(6):e0218215. doi: 10.1371/journal.pone.0218215. eCollection 2019.

13.

Pilot study of a ketogenic diet in relapsing-remitting MS.

Brenton JN, Banwell B, Bergqvist AGC, Lehner-Gulotta D, Gampper L, Leytham E, Coleman R, Goldman MD.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 12;6(4):e565. doi: 10.1212/NXI.0000000000000565. eCollection 2019 Jul.

14.

Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG.

Waubant E, Banwell B, Wassmer E, Sormani MP, Amato MP, Hintzen R, Krupp L, Rostásy K, Tenembaum S, Chitnis T; IPMSSG.

Neurology. 2019 May 28;92(22):e2538-e2549. doi: 10.1212/WNL.0000000000007572. Epub 2019 May 1. Erratum in: Neurology. 2019 Oct 1;93(14):647.

15.

Are children with multiple sclerosis really "old" adults.

Banwell B.

Mult Scler. 2019 Jun;25(7):888-890. doi: 10.1177/1352458519841505. Epub 2019 Apr 4. No abstract available.

PMID:
30945591
16.

Enhanced Recruitment During Executive Control Processing in Cognitively Preserved Patients With Pediatric-Onset MS.

Barlow-Krelina E, Turner GR, Akbar N, Banwell B, Lysenko M, Yeh EA, Narayanan S, Collins DL, Aubert-Broche B, Till C.

J Int Neuropsychol Soc. 2019 Apr;25(4):432-442. doi: 10.1017/S135561771800125X. Epub 2019 Feb 28.

PMID:
30813973
17.

Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis.

Mexhitaj I, Nyirenda MH, Li R, O'Mahony J, Rezk A, Rozenberg A, Moore CS, Johnson T, Sadovnick D, Collins DL, Arnold DL, Gran B, Yeh EA, Marrie RA, Banwell B, Bar-Or A.

Brain. 2019 Mar 1;142(3):617-632. doi: 10.1093/brain/awz017.

PMID:
30759186
18.

A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis.

Fadda G, Brown RA, Magliozzi R, Aubert-Broche B, O'Mahony J, Shinohara RT, Banwell B, Marrie RA, Yeh EA, Collins DL, Arnold DL, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

Ann Neurol. 2019 Mar;85(3):340-351. doi: 10.1002/ana.25429. Epub 2019 Feb 20.

19.

Treatment Approaches for MOG-Ab-Associated Demyelination in Children.

Hacohen Y, Banwell B.

Curr Treat Options Neurol. 2019 Jan 22;21(1):2. doi: 10.1007/s11940-019-0541-x. Review.

20.

Author Correction: Neuroimmune disorders of the central nervous system in children in the molecular era.

Wells E, Hacohen Y, Waldman A, Tillema JM, Soldatos A, Ances B, Benseler S, Bielekova B, Dale RC, Dalmau J, Gaillard W, Gorman M, Greenberg B, Hyslop A, Pardo CA, Tasker RC, Yeh EA, Bar-Or A, Pittock S, Vanderver A, Banwell B; attendees of the International Neuroimmune Meeting.

Nat Rev Neurol. 2018 Dec;14(12):749. doi: 10.1038/s41582-018-0077-9.

PMID:
30442924
21.

Incidence and prevalence of MS in children: A population-based study in Ontario, Canada.

Marrie RA, O'Mahony J, Maxwell C, Ling V, Yeh EA, Arnold DL, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2018 Oct 23;91(17):e1579-e1590. doi: 10.1212/WNL.0000000000006395. Epub 2018 Sep 26.

PMID:
30258022
22.

Pediatric Multiple Sclerosis: an Update.

Otallah S, Banwell B.

Curr Neurol Neurosci Rep. 2018 Sep 18;18(11):76. doi: 10.1007/s11910-018-0886-7. Review.

PMID:
30229541
23.

Physical activity and dentate gyrus volume in pediatric acquired demyelinating syndromes.

Longoni G, Brown RA, Aubert-Broche B, Grover SA, Branson HM, Fetco D, Bar-Or A, Marrie RA, Motl RW, Collins DL, Narayanan S, Arnold DL, Banwell B, Yeh EA.

Neurol Neuroimmunol Neuroinflamm. 2018 Sep 6;5(6):e499. doi: 10.1212/NXI.0000000000000499. eCollection 2018 Nov.

24.

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.

Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J; PARADIGMS Study Group.

N Engl J Med. 2018 Sep 13;379(11):1017-1027. doi: 10.1056/NEJMoa1800149.

25.

Neurotoxicity after CTL019 in a pediatric and young adult cohort.

Gofshteyn JS, Shaw PA, Teachey DT, Grupp SA, Maude S, Banwell B, Chen F, Lacey SF, Melenhorst JJ, Edmonson MJ, Panzer J, Barrett DM, McGuire JL.

Ann Neurol. 2018 Oct;84(4):537-546. doi: 10.1002/ana.25315. Epub 2018 Sep 26.

26.

MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.

Fadda G, Brown RA, Longoni G, Castro DA, O'Mahony J, Verhey LH, Branson HM, Waters P, Bar-Or A, Marrie RA, Yeh EA, Narayanan S, Arnold DL, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Lancet Child Adolesc Health. 2018 Mar;2(3):191-204. doi: 10.1016/S2352-4642(18)30026-9. Epub 2018 Feb 1.

PMID:
30169254
27.

Clinical implications of status epilepticus in children.

Massey S, Banwell B.

Lancet Child Adolesc Health. 2018 Feb;2(2):81-83. doi: 10.1016/S2352-4642(17)30175-X. Epub 2017 Dec 7. No abstract available.

28.

Pediatric-onset multiple sclerosis is associated with reduced parental health-related quality of life and family functioning.

O'Mahony J, Marrie RA, Laporte A, Bar-Or A, Yeh EA, Brown A, Dilenge ME, Banwell B.

Mult Scler. 2019 Oct;25(12):1661-1672. doi: 10.1177/1352458518796676. Epub 2018 Aug 30.

PMID:
30160208
29.

A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit.

Magalhaes S, Banwell B, Bar-Or A, Fortier I, Hanwell HE, Lim M, Matt GE, Neuteboom RF, O'Riordan DL, Schneider PK, Pugliatti M, Shatenstein B, Tansey CM, Wassmer E, Wolfson C.

Mult Scler. 2019 Jul;25(8):1170-1177. doi: 10.1177/1352458518783345. Epub 2018 Jun 22.

30.

Neuroimmune disorders of the central nervous system in children in the molecular era.

Wells E, Hacohen Y, Waldman A, Tillema JM, Soldatos A, Ances B, Benseler S, Bielekova B, Dale RC, Dalmau J, Gaillard W, Gorman M, Greenberg B, Hyslop A, Pardo CA, Tasker RC, Yeh EA, Bar-Or A, Pittock S, Vanderver A, Banwell B; attendees of the International Neuroimmune Meeting.

Nat Rev Neurol. 2018 Jul;14(7):433-445. doi: 10.1038/s41582-018-0024-9. Review. Erratum in: Nat Rev Neurol. 2018 Dec;14(12):749.

PMID:
29925924
31.

Involvement of the Amygdala in Memory and Psychosocial Functioning in Pediatric-Onset Multiple Sclerosis.

Green R, Adler A, Banwell BL, Fabri TL, Yeh EA, Collins DL, Sled JG, Narayanan S, Till C.

Dev Neuropsychol. 2018;43(6):524-534. doi: 10.1080/87565641.2018.1485679. Epub 2018 Jun 18.

PMID:
29911891
32.

Detection and clinical correlation of leukocortical lesions in pediatric-onset multiple sclerosis on multi-contrast MRI.

Maranzano J, Till C, Assemlal HE, Fonov V, Brown R, Araujo D, O'Mahony J, Yeh EA, Bar-Or A, Marrie RA, Collins L, Banwell B, Arnold DL, Narayanan S.

Mult Scler. 2019 Jun;25(7):980-986. doi: 10.1177/1352458518779952. Epub 2018 Jun 1.

PMID:
29852831
33.

Imaging Pediatric Multiple Sclerosis-Challenges and Recent Advances.

Parmar K, Banwell BL, Akbar N, Bigi S.

Neuropediatrics. 2018 Jun;49(3):165-172. doi: 10.1055/s-0038-1635123. Epub 2018 Feb 26. Review.

PMID:
29482255
34.

The contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk.

Lavery AM, Collins BN, Waldman AT, Hart CN, Bar-Or A, Marrie RA, Arnold D, O'Mahony J, Banwell B.

Mult Scler. 2019 Apr;25(4):515-522. doi: 10.1177/1352458518757089. Epub 2018 Feb 2.

PMID:
29393768
35.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977
36.

Correction to: Impact of an electronic monitoring device and behavioural feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.

Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE; Pediatric MS Adherence Study Group.

Qual Life Res. 2018 Apr;27(4):1117. doi: 10.1007/s11136-017-1773-4.

37.

Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis.

Brenton JN, Schreiner T, Karoscik K, Richter M, Ferrante S, Waldman A, Banwell B.

J Neurol. 2018 Feb;265(2):417-423. doi: 10.1007/s00415-017-8715-5. Epub 2017 Dec 22.

PMID:
29273844
38.

Increased relapse rate during pregnancy and postpartum in neuromyelitis optica.

Banwell B, Marrie RA.

Neurology. 2017 Nov 28;89(22):2220-2221. doi: 10.1212/WNL.0000000000004721. Epub 2017 Nov 1. No abstract available.

PMID:
29093071
39.

Complex genomic rearrangement in SPG11 due to a DNA replication-based mechanism.

Baskin B, Kalia LV, Banwell BL, Ray PN, Yoon G.

Mov Disord. 2017 Dec;32(12):1792-1794. doi: 10.1002/mds.27188. Epub 2017 Oct 30. No abstract available.

PMID:
29082553
40.

A feasibility study of working memory training for individuals with paediatric-onset multiple sclerosis.

Till C, Kuni B, De Somma E, Yeh EA, Banwell B.

Neuropsychol Rehabil. 2019 Sep;29(8):1177-1192. doi: 10.1080/09602011.2017.1372786. Epub 2017 Sep 18.

PMID:
28920511
41.

Maturational Trajectory of Processing Speed Performance in Pediatric Multiple Sclerosis.

Akbar N, Signori A, Amato MP, Sormani MP, Portaccio E, Niccolai C, Goretti B, Till C, Banwell B.

Dev Neuropsychol. 2017;42(5):299-308. doi: 10.1080/87565641.2017.1351974. Epub 2017 Sep 5.

PMID:
28872902
42.

Obituary: Jessica Anne Panzer, MD, PhD.

Ortiz-Gonzalez X, Goldberg EM, Banwell B.

Pediatr Neurol. 2017 Oct;75:4-5. doi: 10.1016/j.pediatrneurol.2017.07.007. Epub 2017 Jul 14. No abstract available.

PMID:
28823630
43.

Common and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients.

Abath Neto O, Moreno CAM, Malfatti E, Donkervoort S, Böhm J, Guimarães JB, Foley AR, Mohassel P, Dastgir J, Bharucha-Goebel DX, Monges S, Lubieniecki F, Collins J, Medne L, Santi M, Yum S, Banwell B, Salort-Campana E, Rendu J, Fauré J, Yis U, Eymard B, Cheraud C, Schneider R, Thompson J, Lornage X, Mesrob L, Lechner D, Boland A, Deleuze JF, Reed UC, Oliveira ASB, Biancalana V, Romero NB, Bönnemann CG, Laporte J, Zanoteli E.

Neuromuscul Disord. 2017 Nov;27(11):975-985. doi: 10.1016/j.nmd.2017.05.016. Epub 2017 May 30.

PMID:
28818389
44.

7T MRI Visualization of Cortical Lesions in Adolescents and Young Adults with Pediatric-Onset Multiple Sclerosis.

Datta R, Sethi V, Ly S, Waldman AT, Narula S, Dewey BE, Sati P, Reich D, Banwell B.

J Neuroimaging. 2017 Sep;27(5):447-452. doi: 10.1111/jon.12465. Epub 2017 Aug 10.

45.

An update on multiple sclerosis in children: diagnosis, therapies, and prospects for the future.

Gordon-Lipkin E, Banwell B.

Expert Rev Clin Immunol. 2017 Oct;13(10):975-989. doi: 10.1080/1744666X.2017.1360135. Epub 2017 Aug 7. Review.

PMID:
28738749
46.

Optical coherence tomography and visual evoked potentials in pediatric MS.

Waldman AT, Liu GT, Lavery AM, Liu G, Gaetz W, Aleman TS, Banwell BL.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 5;4(4):e356. doi: 10.1212/NXI.0000000000000356. eCollection 2017 Jul.

47.

Adverse events associated with a large dose of intravenous lipid emulsion for suspected local anesthetic toxicity.

Corwin DJ, Topjian A, Banwell BL, Osterhoudt K.

Clin Toxicol (Phila). 2017 Jul;55(6):603-607. doi: 10.1080/15563650.2017.1294693. Epub 2017 Feb 26.

PMID:
28489457
48.

Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.

Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE; Pediatric MS Adherence Study Group.

Qual Life Res. 2017 Sep;26(9):2333-2349. doi: 10.1007/s11136-017-1571-z. Epub 2017 Apr 9. Erratum in: Qual Life Res. 2017 Dec 23;:.

49.

Monophasic demyelination reduces brain growth in children.

Aubert-Broche B, Weier K, Longoni G, Fonov VS, Bar-Or A, Marrie RA, Yeh EA, Narayanan S, Arnold DL, Verhey LH, Banwell B, Collins DL; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2017 May 2;88(18):1744-1750. doi: 10.1212/WNL.0000000000003884. Epub 2017 Apr 5.

50.

White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.

Longoni G, Brown RA, MomayyezSiahkal P, Elliott C, Narayanan S, Bar-Or A, Marrie RA, Yeh EA, Filippi M, Banwell B, Arnold DL; Canadian Pediatric Demyelinating Disease Network.

Brain. 2017 May 1;140(5):1300-1315. doi: 10.1093/brain/awx041.

PMID:
28334875

Supplemental Content

Loading ...
Support Center